High hepatitis C incidence in new injecting drug users: a policy failure?
- 1 February 2007
- journal article
- research article
- Published by Elsevier BV in Australian and New Zealand Journal of Public Health
- Vol. 31 (1), 30-35
- https://doi.org/10.1111/j.1753-6405.2007.00007.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Incidence and risk factors for hepatitis C seroconversion in injecting drug users in AustraliaAddiction, 2006
- Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort studyBMJ, 2004
- Molecular Epidemiology of Hepatitis C Virus in a Social Network of Injection Drug UsersThe Journal of Infectious Diseases, 2004
- Hepatitis C Virus Infection Among Injection Drug UsersEpidemiology, 2004
- Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and RisksThe Journal of Infectious Diseases, 2002
- Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug usersHepatology, 2002
- Sharing of drug preparation equipment as a risk factor for hepatitis CAmerican Journal of Public Health, 2001
- Reliability of Self-reported Human Immunodeficiency Virus Risk Behaviors in a Residential Drug Treatment PopulationAmerican Journal of Epidemiology, 1996
- Socially desirable responding and self‐reported HIV infection risk behaviors among intravenous drug usersAddiction, 1993
- Prevalence, Incidence, and Risk Factors of Hepatitis C Virus Infection among Drug Users in AmsterdamThe Journal of Infectious Diseases, 1990